Mecobalamin - EisaiAlternative Names: E 0302
Latest Information Update: 30 Mar 2016
At a glance
- Originator Eisai Co Ltd
- Class Vitamin B12 analogues; Vitamins
- Mechanism of Action Methyltransferase stimulants; Vitamin B12 receptor protein agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preregistration Amyotrophic lateral sclerosis